Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P64
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -0.50% |
| Q2 2025 | 43.07% |
| Q1 2025 | -17.82% |
| Q4 2024 | -22.36% |
| Q3 2024 | -14.18% |
| Q2 2024 | 17.17% |
| Q1 2024 | -32.05% |
| Q4 2023 | -30.03% |
| Q3 2023 | -13.60% |
| Q2 2023 | -35.25% |
| Q1 2023 | 73.06% |
| Q4 2022 | -37655.56% |
| Q3 2022 | 99.50% |
| Q2 2022 | -71.72% |
| Q1 2022 | -4318.92% |
| Q4 2021 | 103.61% |
| Q3 2021 | -125.27% |
| Q2 2021 | -17.88% |
| Q1 2021 | -60.83% |
| Q4 2020 | 50.05% |
| Q3 2020 | 61.90% |
| Q2 2020 | -585.00% |
| Q1 2020 | 0.00% |